Company news
Innovotech Inc. (TSXV:IOT) news
Innovotech Inc. news releases on 6ix. Latest, May 23, 2023: Innovotech Reports a Loss for its First Quarter Ended March 31, 2023
Press releases — page 2
Innovotech Reports a Loss for its First Quarter Ended March 31, 2023
May 23, 2023
InnovoSIL TM-1 Antimicrobial Silver Works Against Candida auris and Superbugs
May 15, 2023
Innovotech Reports a Loss for Fiscal 2022
April 25, 2023
INNOVOTECH Reports a Profitable Third Quarter and Sees Its MBEC Assay Plate Used In Space
November 15, 2022
Innovotech Inc. Grants 150,000 Incentive Stock Options and Reports Retirement of a Director
October 25, 2022
INNOVOTECH Reports a Loss for the First 6 Months to June 30th, 2022
August 16, 2022
INNOVOTECH Reports Decreased Net Profit in the First 3 Months of 2022 to March 31st, (Q1)
May 24, 2022
INNOVOTECH Reports Increased Net Profit in 2021
April 26, 2022
Termination of Collaboration Agreement for InnovoSIL(tm)-1 Antimicrobial Silver
January 21, 2022
Innovotech Reports Nine-Month Results to September 30, 2021
November 16, 2021
Innovotech Reports Six-Month Results to June 30, 2021
August 24, 2021
Innovotech Reports Profitable First Quarter (Q1) to March 31st
May 25, 2021
Innovotech Reports Profitable 2020 Year-End Results
April 20, 2021
Innovotech Announces Appointment of Dr. Tyler Boone as COO
April 14, 2021
Alan C. Savage Files Early Warning Report
March 8, 2021
Innovotech Announces TSX Venture Exchange Final Approval of CanBiocin Debenture Acquisition
February 23, 2021
Approval of Innovotech Acquisition of a 60% Interest in Nou Life Sciences Inc.
January 19, 2021
Innovotech Reports Termination of Agreement for Acquisition of Shares of Listed Health Sector Companies
January 18, 2021
Innovotech Reports Acquisition of Shares of Listed Health Sector Companies
January 5, 2021
Innovotech Reports Improved Three and Nine-Month Results to September 30th, 2020
November 12, 2020
Innovotech Announces Grant of Stock Options
October 20, 2020
Innovotech Acquires 8% CanBiocin Inc. Convertible Debenture, Repays $100,000 Shareholder Loan
October 16, 2020
Innovotech Announces Final Approval for Closing of Private Placement
September 2, 2020
Innovotech Announces Unit Offering
August 24, 2020
Innovotech Acquires Option to Earn 60% Interest in Nou Life Sciences Inc.
August 18, 2020
Innovotech Reports 3 and 6-Month Financial Results to June 30, 2020
August 11, 2020
Innovotech Signs Collaboration Agreement for InnovoSIL(TM)-1
July 14, 2020
Innovotech Inc. Reports Financial Results for the 1st Quarter Ended March 31, 2020
May 28, 2020
Innovotech Reports 2019 Financial Results
April 28, 2020
Impact of the COVID-19 Pandemic on Innovotech Inc.
March 31, 2020
Innovotech Submits New Provisional Patent Application
February 20, 2020
Innovotech Appoints New Board Member Dr. Karen Farkas
December 18, 2019
Innovotech Reviews Progress, Redirection and Innovation Over 2018 - 2019
December 10, 2019
Innovotech Reports Profitable Third Quarter
November 20, 2019
Alan C. Savage Files Early Warning Report re Innovotech
October 23, 2019
Innovotech Issues Stock Options to Directors and Employees
October 22, 2019
Innovotech Reports Issue of U.S. Patent No. 10,434,210 for Antimicrobial Silver Compounds in Gels
October 18, 2019
Innovotech Inc Reports 3 and 6-month Results to June 30, 2019
August 20, 2019
Innovotech Reports Notice of Allowance of a US Patent for Antimicrobial Silver Iodates in Gels
July 29, 2019
Innovotech Reports on Changes to its Board of Directors
July 19, 2019
Innovotech Reports Amended Terms of Line of Credit, Comments on Business Activity
July 15, 2019
Innovotech Announces Completion of Private Placement, Appointment of Alan Savage to the Board of Directors and Amendment to Stock Options
May 8, 2017